全文获取类型
收费全文 | 6571篇 |
免费 | 629篇 |
国内免费 | 2篇 |
出版年
2023年 | 23篇 |
2022年 | 63篇 |
2021年 | 131篇 |
2020年 | 64篇 |
2019年 | 77篇 |
2018年 | 98篇 |
2017年 | 77篇 |
2016年 | 144篇 |
2015年 | 271篇 |
2014年 | 306篇 |
2013年 | 364篇 |
2012年 | 472篇 |
2011年 | 504篇 |
2010年 | 320篇 |
2009年 | 262篇 |
2008年 | 398篇 |
2007年 | 390篇 |
2006年 | 323篇 |
2005年 | 383篇 |
2004年 | 377篇 |
2003年 | 365篇 |
2002年 | 364篇 |
2001年 | 73篇 |
2000年 | 51篇 |
1999年 | 87篇 |
1998年 | 91篇 |
1997年 | 70篇 |
1996年 | 59篇 |
1995年 | 52篇 |
1994年 | 56篇 |
1993年 | 72篇 |
1992年 | 48篇 |
1991年 | 40篇 |
1990年 | 54篇 |
1989年 | 28篇 |
1988年 | 35篇 |
1987年 | 24篇 |
1986年 | 40篇 |
1985年 | 43篇 |
1984年 | 40篇 |
1983年 | 29篇 |
1982年 | 51篇 |
1981年 | 37篇 |
1980年 | 37篇 |
1978年 | 29篇 |
1977年 | 25篇 |
1976年 | 32篇 |
1975年 | 25篇 |
1974年 | 20篇 |
1973年 | 33篇 |
排序方式: 共有7202条查询结果,搜索用时 15 毫秒
1.
Burt V. Bronk Joe D. Patton David N. Mellard 《Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression》1982,697(3):278-285
Chick embryo fibroblasts were treated with the monofunctional alkylating agent methylmethane sulfonate at various concentrations for 1 h at 42°C, rinsed and then incubated post-treatment at various temperatures at which the kinetics of alkali-labile bond disappearance was followed. Growth experiments showed that these cells grew similarly at temperatures of either 37°C or 42°C. Repair as assessed by removal of alkali-labile bond was also similar for postincubation in the temperature range 37–42°C for damage due to methylmethane sulfonate treatment at concentrations less than 1.5 mM. When the postincubation temperature was raised higher than 42.5–43°C, this type of repair was stopped. The normal internal body temperature of adult chickens is about 41.6°C. Hence the present finding indicates that chick cells are much more severely restricted in DNA repair at temperatures above normal than are mammalian cells, which can function in this respect for several deg. C above 37°C. 相似文献
2.
3.
4.
5.
6.
Joe T. Ritchie 《Plant and Soil》1981,58(1-3):81-96
7.
8.
Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype 总被引:1,自引:0,他引:1
The endothelial cells that form capillaries in the brain are highly specialized, with tight junctions that minimize paracellular transport and an array of broad-spectrum efflux pumps that make drug delivery to the brain extremely challenging. One of the major limitations in blood-brain barrier research and the development of drugs to treat central nervous system diseases is the lack of appropriate cell lines. Recent reports indicate that the derivation of human brain microvascular endothelial cells (hBMECs) from human induced pluripotent stem cells (iPSCs) may provide a solution to this problem. Here we demonstrate the derivation of hBMECs extended to two new human iPSC lines: BC1 and GFP-labeled BC1. These hBMECs highly express adherens and tight junction proteins VE-cadherin, ZO-1, occludin, and claudin-5. The addition of retinoic acid upregulates VE-cadherin expression, and results in a significant increase in transendothelial electrical resistance to physiological values. The permeabilities of tacrine, rhodamine 123, and Lucifer yellow are similar to values obtained for MDCK cells. The efflux ratio for rhodamine 123 across hBMECs is in the range 2–4 indicating polarization of efflux transporters. Using the rod assay to assess cell organization in small vessels and capillaries, we show that hBMECs resist elongation with decreasing diameter but show progressive axial alignment. The derivation of hBMECs with a blood-brain barrier phenotype from the BC1 cell line highlights that the protocol is robust. The expression of GFP in hBMECs derived from the BC1-GFP cell line provides an important new resource for BBB research. 相似文献
9.
Jonas G. Barlind Linda K. Buckett Sharon G. Crosby Öjvind Davidsson Hans Emtenäs Anne Ertan Ulrik Jurva Malin Lemurell Pablo Morentin Gutierrez Karolina Nilsson Gavin O’Mahony Annika U. Petersson Alma Redzic Fredrik Wågberg Zhong-Qing Yuan 《Bioorganic & medicinal chemistry letters》2013,23(9):2721-2726
[Acyl CoA]monoacylglycerol acyltransferase 2 (MGAT2) is of interest as a target for therapeutic treatment of diabetes, obesity and other diseases which together constitute the metabolic syndrome. In this Letter we report our discovery and optimisation of a novel series of MGAT2 inhibitors. The development of the SAR of the series and a detailed discussion around some key parameters monitored and addressed during the lead generation phase will be given. The in vivo results from an oral lipid tolerance test (OLTT) using the MGAT2 inhibitor (S)-10, shows a significant reduction (68% inhibition relative to na?ve, p <0.01) in plasma triacylglycerol (TAG) concentration. 相似文献
10.
Xu Zhang Wei Zhang Santosh L. Saraf Mehdi Nouraie Jin Han Michel Gowhari Johara Hassan Galina Miasnikova Adelina Sergueeva Sergei Nekhai Rick Kittles Roberto F. Machado Joe G. N. Garcia Mark T. Gladwin Martin H. Steinberg Paola Sebastiani Donald A. McClain Victor R. Gordeuk 《Human genetics》2015,134(8):895-904